US Suspended Johnson&Johnson’s Vaccine. Suspected Blood Clots
As soon as I finished writing the article on the research conducted by the University Hospital of Oslo (Norway) on the well-known correlation between the Astrazeneca vaccine and cases of lethal thrombosis, from the USA, another disturbing news arrives.
«Federal health agencies on Tuesday recommended pausing the use of the Johnson & Johnson vaccine after a small number of people experienced “a rare and severe type of blood clot” after receiving the shot. The Food and Drug Administration and the Centers for Disease Control and Prevention issued a statement saying they were “recommending a pause in the use of this vaccine out of an abundance of caution.”» reported NBC.
Some 6.8 million people have received the single-shot vaccine in the United States. Of these, six have experienced the clot, the agencies said, adding: “Right now, these adverse events appear to be extremely rare.” The news was first reported by The New York Times.
In a statement, Johnson & Johnson said it was aware that blood clots had been reported with some Covid-19 vaccines, but that “no clear causal relationship has been established between these rare events” and its shot.
“We continue to work closely with experts and regulators to assess the data and support the open communication of this information to healthcare professionals and the public,” it said.
The six people who experienced clots were all women between the ages of 18 and 48, the FDA and CDC said. They had what’s called a cerebral venous sinus thrombosis, or CVST, as well as low levels of blood platelets.